| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
70,327 |
63,402 |
$4.71M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
43,491 |
43,155 |
$3.28M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,422 |
7,063 |
$496K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,123 |
4,093 |
$297K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
5,797 |
5,625 |
$195K |
| 99070 |
|
4,754 |
3,909 |
$158K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,502 |
1,422 |
$121K |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
909 |
822 |
$90K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,077 |
1,995 |
$27K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,844 |
2,935 |
$27K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,810 |
4,745 |
$18K |
| 0002A |
|
178 |
178 |
$7K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
203 |
193 |
$5K |
| 0001A |
|
138 |
138 |
$5K |
| 71046 |
Radiologic examination, chest; 2 views |
262 |
259 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
43 |
43 |
$4K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
44 |
44 |
$4K |
| 0004A |
|
89 |
89 |
$4K |
| 0012A |
|
76 |
76 |
$3K |
| 0064A |
|
74 |
74 |
$3K |
| 81025 |
|
1,288 |
1,263 |
$2K |
| 0011A |
|
55 |
55 |
$2K |
| 81003 |
|
2,590 |
2,518 |
$2K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
15 |
14 |
$2K |
| 81002 |
|
1,115 |
1,099 |
$1K |
| 99215 |
Prolong outpt/office vis |
14 |
13 |
$1K |
| 99072 |
|
983 |
891 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
203 |
196 |
$1K |
| 99000 |
|
1,414 |
1,364 |
$957.72 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
179 |
173 |
$872.73 |
| 73630 |
|
40 |
37 |
$722.88 |
| 73610 |
|
41 |
40 |
$677.40 |
| 0003A |
|
12 |
12 |
$480.00 |
| 69209 |
|
27 |
26 |
$178.56 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
13 |
13 |
$144.49 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
26 |
26 |
$106.37 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
16 |
16 |
$81.56 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
20 |
20 |
$51.31 |
| A4927 |
Gloves, non-sterile, per 100 |
205 |
198 |
$16.84 |
| A6413 |
Adhesive bandage, first-aid type, any size, each |
24 |
24 |
$12.00 |
| A5120 |
Skin barrier, wipes or swabs, each |
12 |
12 |
$1.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
13 |
12 |
$0.75 |